Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases

Clinical trial NCT06614270 · RECRUITING

Trial details

NCT number: NCT06614270
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Systemic Sclerosis (SSc)ANCA Associated Vasculitis (AAV)Idiopathic Inflammatory Myopathy (IIM)Sjogren's Syndrome Antiphospholipid Syndrome Systemic Lupus Erythematosus

Start date: 2025-01-06
Primary completion: 2026-01-06
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.